Please login to the form below

The Clinical Trial Company

The Clinical Trial Company (TCTC) targets medium size clinical trials and novel products which lack a classical road map to the market. Large CROs prioritise studies from the big pharma companies, for good business reasons. However, this approach sometimes disadvantages their SME clients who are equally keen to complete their clinical trials quickly. TCTC are experts in advanced therapies, such as cell and gene therapies, as well as orphan drug and biologics.

This is a FREE listing




Below are full profiles from other companies in this area

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of patients is at the heart of our programmes; Sciterion are experts at rigorous insight generation and multi-stakeholder co-creation. Through a deep understanding of health behaviour, we align key stakeholder touchpoints to deliver intelligent, highly impactful and clinically relevant programmes. Our industry- leading standards of medical and scientific excellence, coupled with robust behavioural knowledge, advances clinical practice and optimises real world patient outcomes.

View profile

Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our collaborative cross-discipline approach enables us to create engaging, effective and measurable campaigns across channels to deliver distinctive solutions at every stage of a product’s lifecycle.

View profile

Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe.

View profile

Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life visit SyneosHealth.com.

View profile

Company Details

The Clinical Trial Company

Telephone:+44 1565 733 772

Address:
Mere View Barn
Park Lane , Pickmere
Knutsford
WA16 0LG
UK

Latest content from PMHub

Confocal Microscope Market to Witness Notable Revenue Growth in North America Owing to Increasing Spending on R&D Initiatives in the Region
Confocal Microscope Market : Segmented by key players - Olympus Corporation, Leica Microsystem, ZEISS Group (Carl Zeiss Meditec AG), Nikon Corporation, Bio-Rad Laboratories, Inc., Bruker Corporation, Oxford Instruments plc., Confocal.nl, ISS.Inc, Thorlabs, Inc among others Future Market Insights
Confocal Microscope Market to Witness Notable Revenue Growth in North America Owing to Increasing Spending on R&D Initiatives in the Region
Confocal Microscope Market : Segmented by key players - Olympus Corporation, Leica Microsystem, ZEISS Group (Carl Zeiss Meditec AG), Nikon Corporation, Bio-Rad Laboratories, Inc., Bruker Corporation, Oxford Instruments plc., Confocal.nl, ISS.Inc, Thorlabs, Inc among others Future Market Insights
Western Blotting Processors Market Growth Challenged by High Costs, Low Innovation, and Unreliability of Automated Devices
Future Market Insights has announced the addition of the “Western Blotting Processors Market: Automated Dry Blotting System Expected to Remain Dominant Product Type During the Forecast Period: Global Industry Analysis (2013 - 2017) & Opportunity Assessment (2018 - 2028)" report to their offering Future Market Insights
High Cost Factor and Health Risks Arising from Surgical Procedures Restraining Revenues in the Hearing Implant Market
Future Market Insights has announced the addition of the “Hearing Implant Market: Cochlear Implant Expected to Remain Dominant Product Type During the Forecast Period: Global Industry Analysis (2013 - 2017) & Opportunity Assessment (2018 - 2028)" report to their offering Future Market Insights